Lower Blood Pressure Goals for Cardiovascular and Renal Risk Reduction: Are They Defensible?

This publication has 11 references indexed in Scilit:

• Long-term Effects of Renin-Angiotensin System–Blocking Therapy and a Low Blood Pressure Goal on Progression of Hypertensive Chronic Kidney Disease in African Americans
  Archives of internal medicine (1960), 2008
• 2007 Guidelines for the Management of Arterial Hypertension
  Journal Of Hypertension, 2007
• Blood Pressure Reduction and Cardiovascular Prevention: An Update Including the 2003-2004 Secondary Prevention Trials
  Hypertension Research, 2005
• Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
  Hypertension, 2003
• Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis
  Annals of Internal Medicine, 2003
• Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
  New England Journal of Medicine, 2003
• Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney DiseaseResults From the AASK Trial
  JAMA, 2002
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
  BMJ, 1998
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
  The Lancet, 1998
• Blood Pressure Control, Proteinuria, and the Progression of Renal Disease
  Annals of Internal Medicine, 1995